Home › Funds › PSP Research LLC › KYMR

PSP Research LLC position in KYMR

KYMERA THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 2,000 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$224K, representing 0.15% of its reported portfolio and ranking #31 among its reported holdings. PSP Research LLC has disclosed KYMR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)2.00K sh
Reported value held$223.58K
Portfolio Weight0.15%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's KYMR position evolved

PSP Research LLC first disclosed a stake in KYMR in Q4 2025 at 6,348 shares (US$494K). The position peaked in Q1 2026 at 6,300 shares, worth US$525K. Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,000 shares valued at US$224K — a reduction of -2,000 shares quarter over quarter.. Notable position changes include a 37% trim in Q2 2026 (shares fell 3% over the following quarter), a 50% trim in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 6.35K $493.94K New
Q1 2026 6.30K $524.73K Reduce
Q2 2026 4.00K $458.68K Reduce
Q3 2026 2.00K $223.58K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has PSP Research LLC held KYMR?

PSP Research LLC has disclosed KYMR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in KYMR?

As of Q3 2026, PSP Research LLC holds 2.00K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $223.58K, representing 0.15% of its reported portfolio and ranking #31.

Has PSP Research LLC been buying or selling KYMR?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in KYMR. The position peaked in Q1 2026 at 6.30K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.